APOB and hyperlipidemia: For example, in a study comparing the frequency of ApoB mutations and lipid composition in full-term newborns, Akisu et al. (2004) demonstrated that CHO and ApoB concentrations in infants with restricted fetal growth were significantly higher than in normal-weight infants, suggesting that such dys lipidemia was associated with an adverse fetal environment.